(1) How was this issue identified? Starting in quarter 1 2007, we noticed the high rate of excess dosing for heparin on our ACTION site reports compared to national rates. (2) What did you do to ...

Patients with high D-dimer levels who are hospitalized with COVID-19—but not those who require ICU-level care—stand to gain a reduction in major thromboembolism and death with therapeutic-dose low ...

Anecdotal reports of subtherapeutic heparin have kept many cardiologists across the world on edge over the past couple of months, although no regulatory authority has yet confirmed a specific problem.

While efforts to make dosing safer in the wake of recent heparin-related deaths make sense, such efforts have created a fresh set of safety concerns for providers who use it, observers say. For one ...

SAN FRANCISCO and FLAGSTAFF, Ariz., June 13, 2024 /PRNewswire/ -- Today, InsightRX and Northern Arizona Healthcare (NAH) announced they will make InsightRX's precision dosing software for heparin ...

Despite national attention, heparin overdoses continue to be an issue for hospitals, a fact underscored by a recent case in which 14 babies at a Texas hospital were given a massive overdose of the ...

For those who suffer potentially dangerous blood clots in the legs and lungs, taking medicine just became a little easier. Giving patients a daily injection of the blood thinner “low-molecular weight ...

THE chief obstacles to the wide-scale use of heparin in the treatment of venous thromboembolic disease, are two: the expense of the available commercial heparin preparations and the transiency of ...

Welcome, everyone. I'm Doctor John Whyte, the Chief Medical Officer at WebMD. And you're watching Coronavirus in Context. One of the things that we've learned over the past 18 months about Coronavirus ...

PMX-60056 Heptagonist Is The Only Reversing Agent for Heparin and Low Molecular Weight Heparins in Clinical Development PMX-60056 is the Company's Second Clinical Trial Initiation in the Past Month ...

The original heparin standing orders used by this site were based on recommendations for the treatment of venous thromboembolic disease. The ACCP consensus document also states that the dosing for ...